These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

513 related items for PubMed ID: 19617014

  • 1. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist inhibits transforming growth factor-beta1 and matrix production in human dermal fibroblasts.
    Zhang GY, Cheng T, Zheng MH, Yi CG, Pan H, Li ZJ, Chen XL, Yu Q, Jiang LF, Zhou FY, Li XY, Yang JQ, Chu TG, Gao WY.
    J Plast Reconstr Aesthet Surg; 2010 Jul; 63(7):1209-16. PubMed ID: 19617014
    [Abstract] [Full Text] [Related]

  • 2. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y, Liu H, Liu F, Liu Y, Li J, Chen X.
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [Abstract] [Full Text] [Related]

  • 3. Troglitazone suppresses transforming growth factor-beta1-induced collagen type I expression in keloid fibroblasts.
    Zhang GY, Yi CG, Li X, Ma B, Li ZJ, Chen XL, Guo SZ, Gao WY.
    Br J Dermatol; 2009 Apr; 160(4):762-70. PubMed ID: 19120328
    [Abstract] [Full Text] [Related]

  • 4. Pioglitazone inhibits cell growth and reduces matrix production in human kidney fibroblasts.
    Zafiriou S, Stanners SR, Saad S, Polhill TS, Poronnik P, Pollock CA.
    J Am Soc Nephrol; 2005 Mar; 16(3):638-45. PubMed ID: 15689403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Interleukin-7 modulates extracellular matrix production and TGF-beta signaling in cultured human subconjunctival fibroblasts.
    Yamanaka O, Saika S, Ikeda K, Miyazaki K, Ohnishi Y, Ooshima A.
    Curr Eye Res; 2006 Jun; 31(6):491-9. PubMed ID: 16769608
    [Abstract] [Full Text] [Related]

  • 10. [Mechanism underlying the inhibitory effects of peroxisome proliferator-activated receptor γ agonists on transforming growth factor β1 in adult skin fibroblasts].
    Yang CZ, Zhang HT, Wang GS, Zhou HQ, Ma C, Hu DH.
    Zhonghua Shao Shang Za Zhi; 2010 Dec; 26(6):448-51. PubMed ID: 21223655
    [Abstract] [Full Text] [Related]

  • 11. [Effects of peroxisome proliferators-activated receptor gamma agonists on transforming growth factor-beta1 and Smads signal pathway: experiment with rat renal fibroblasts].
    Wang WM, Liu F, Chen N.
    Zhonghua Yi Xue Za Zhi; 2006 Mar 21; 86(11):740-4. PubMed ID: 16681946
    [Abstract] [Full Text] [Related]

  • 12. [Transfection of recombinant bone morphogenetic protein-7 expressing plasmid into cultured human renal tubular epithelial cells attenuates the extracellular matrix accumulation induced by transforming growth factor-beta].
    Li Y, Chen N, Yu HJ, Dong XP, Huang QH.
    Zhonghua Yi Xue Za Zhi; 2006 Feb 28; 86(8):544-8. PubMed ID: 16681885
    [Abstract] [Full Text] [Related]

  • 13. [Effects of aldosterone on synthesis of fibronectin and expression of transforming growth factor-beta1 mRNA in cultured rat mesangial cells].
    Li XD, Chen XW, Tang DS, Liang D, Liu HF.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb 28; 23(2):140-2. PubMed ID: 17286908
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor-gamma agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts.
    Zhang J, Fang NY, Gao PJ, Wu LY, Han WQ, Guo SJ, Shen WL, Zhu DL.
    Clin Exp Pharmacol Physiol; 2008 Jan 28; 35(1):72-7. PubMed ID: 18047631
    [Abstract] [Full Text] [Related]

  • 15. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
    Schiefelbein D, Seitz O, Goren I, Dissmann JP, Schmidt H, Bachmann M, Sader R, Geisslinger G, Pfeilschifter J, Frank S.
    Mol Pharmacol; 2008 Oct 28; 74(4):952-63. PubMed ID: 18599600
    [Abstract] [Full Text] [Related]

  • 16. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S, Masaki T, Arakawa T, Takahashi S, Kawai T, Nakashima A, Naito T, Kohno N, Yorioka N.
    Transplantation; 2007 Jul 27; 84(2):207-13. PubMed ID: 17667812
    [Abstract] [Full Text] [Related]

  • 17. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts.
    Fan SQ, Cai JL, Qin LY, Wang ZH, Liu ZZ, Sun ML.
    Ann Plast Surg; 2008 Mar 27; 60(3):299-305. PubMed ID: 18443513
    [Abstract] [Full Text] [Related]

  • 18. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M, Lee TW, Mok TS, Warner TD, Yim AP, Chen GG.
    J Cell Biochem; 2005 Nov 01; 96(4):760-74. PubMed ID: 16149072
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 01; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 20. Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts.
    Wang W, Liu F, Chen N.
    Mediators Inflamm; 2007 Jun 01; 2007():62641. PubMed ID: 18274641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.